Investor · New York, NY
Kevin Chavers
Open Kevin in the network graph →Capital
$741.0M
across filings
Active
Oct 2019
to Jul 2025
Most-connected co-filers (99)
Darien J. Parhad · Chicago, IL8 sharedPatrick J. Morris · Chicago, IL8 sharedAntonio J. Gracias · CHICAGO, IL8 sharedRicardo Lombardi · New York, NY8 sharedJeffrey J. Aronin · Chicago, IL8 sharedAmit Assaraf · New York, NY7 sharedAl C. Laskaj · NEW YORK, NY7 sharedPatrick N. Nolan · Atlanta, GA7 sharedWilliam D. Rahm · New York, NY7 sharedFrancis C. Poli · New York, NY7 sharedDana C. Devivo · NEW YORK, NY7 sharedDoug Mcneely · New York, NY4 sharedEric Van Nostrand · New York, NY4 sharedAndrew Farris · Princeton, NJ4 sharedBruce Elliott · LOS ANGELES, CA2 sharedChenavari Credit Partners LLP · London, United Kingdom2 sharedJerome Leyvigne · London, United Kingdom2 sharedDon Miller · SAN FRANCISCO, CA2 sharedKaren Allen · Oklahoma City, OK2 sharedTeresa O'Flynn · Dublin 1, Ireland2 sharedJuan A. Leautaud · Mexico City, O52 sharedDag Skattum · London, United Kingdom2 sharedDaniel Sefcik · New York, NY2 sharedKen Saffold · Atlanta, GA2 shared Recent filings (12)
Paragon Biosciences Emalex Capital, Inc.Jul 2025 · 20 co-filers$270.0MParagon Biosciences Emalex Capital, Inc.Mar 2025 · 20 co-filers$242.0MParagon Biosciences Emalex Capital, Inc.Nov 2022 · 11 co-filers$250.0MParagon Biosciences Emalex Capital, Inc.Nov 2022 · 11 co-filers$25.0MParagon Biosciences Emalex Capital, Inc.Nov 2022 · 11 co-filers$250.0MBlackRock Impact Opportunities Fund, L.P.Mar 2022 · 50 co-filersBlackRock Impact Opportunities Fund, L.P.Mar 2021 · 50 co-filersParagon Biosciences Emalex Capital, Inc.Mar 2021 · 11 co-filers$35.0MParagon Biosciences Emalex Capital, Inc.Mar 2021 · 11 co-filers$35.0MHumphreys Fund I REIT, LLCJan 2020 · 27 co-filers$63KParagon Biosciences Emalex Capital, Inc.Oct 2019 · 11 co-filers$37.4MHUMPHREYS FUND III, LPOct 2019 · 26 co-filers$150.0M Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Kevin in the interactive graph →